No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Chimeric Clocks $4.17M R&D Tax Rebate From Canberra
Chimeric Therapeutics Ltd: Chimeric receives $4.17m R&D tax incentive
Chimeric Therapeutics Ltd: Annual Report 2024
Chimeric Therapeutics Ltd: 2024 Annual Report update
Chimeric Therapeutics Ltd: Appendix 4E and Preliminary Final Report
Chimeric Therapeutics Concludes GMP Manufacturing for CHM CDH17 CAR-T Trial
No Data